ACCORD COPD II: A randomized clinical trial to evaluate the 12-week efficacy and safety of twice-daily aclidinium bromide in chronic obstructive pulmonary disease patients

Stephen I. Rennard, Paul D. Scanlon, Gary T. Ferguson, Ludmyla Rekeda, Brian T. Maurer, Esther Garcia Gil, Cynthia F. Caracta

Research output: Contribution to journalArticle

32 Scopus citations
Original languageEnglish (US)
Pages (from-to)893-904
Number of pages12
JournalClinical Drug Investigation
Volume33
Issue number12
DOIs
Publication statusPublished - Dec 1 2013

    Fingerprint

Cite this

ACCORD COPD II : A randomized clinical trial to evaluate the 12-week efficacy and safety of twice-daily aclidinium bromide in chronic obstructive pulmonary disease patients. / Rennard, Stephen I.; Scanlon, Paul D.; Ferguson, Gary T.; Rekeda, Ludmyla; Maurer, Brian T.; Garcia Gil, Esther; Caracta, Cynthia F.

In: Clinical Drug Investigation, Vol. 33, No. 12, 01.12.2013, p. 893-904.

Research output: Contribution to journalArticle